Oncorus Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 64

Employees

  • Latest Deal Type
  • Liquidation

Oncorus General Information

Description

Oncorus Inc is a preclinical-stage biopharmaceutical company focused on the intravenous administration of self-amplifying RNA to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its pipeline product includes ONCR-021 and ONCR-788 which are based on coxsackievirus A21 or CVA21, and Seneca Valley Virus, or SVV, respectively.

Contact Information

Website
www.oncorus.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 4 Corporate Drive
  • Andover, MA 01810
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4 Corporate Drive
  • Andover, MA 01810
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncorus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 01-Jun-2023 Completed Bankruptcy: Liquidation
5. 2PO 12-Feb-2021 Completed Generating Revenue
4. IPO 02-Oct-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 20-Dec-2019 Completed Generating Revenue
2. Early Stage VC (Series A2) 15-Dec-2016 $23.8M $61M Completed Generating Revenue
1. Early Stage VC (Series A1) 19-Jul-2016 $37.2M $37.2M Completed Generating Revenue
To view Oncorus’s complete valuation and funding history, request access »

Oncorus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-1
To view Oncorus’s complete cap table history, request access »

Oncorus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Oncorus Inc is a preclinical-stage biopharmaceutical company focused on the intravenous administration of self-amplifyin
Drug Discovery
Andover, MA
64 As of 2022

San Carlos, CA
 

Westlake Village, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncorus Competitors (97)

One of Oncorus’s 97 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iovance Biotherapeutics Corporation San Carlos, CA
Genelux Formerly VC-backed Westlake Village, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Xenetic Biosciences Corporation Framingham, MA
Corbus Pharmaceuticals Holdings Formerly VC-backed Norwood, MA
You’re viewing 5 of 97 competitors. Get the full list »

Oncorus Patents

Oncorus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023212685-A2 Production of rna polynucleotides encoding picornavirus Inactive 29-Apr-2022
WO-2023107878-A1 Compositions and methods of seneca valley virus (svv) related cancer therapy Inactive 06-Dec-2021
WO-2023034867-A1 Engineered oncolytic herpesviruses Inactive 31-Aug-2021
WO-2022173531-A1 Compounds, compositions, and methods of using thereof Inactive 10-Feb-2021
WO-2022173531-A9 Compounds, compositions, and methods of using thereof Inactive 10-Feb-2021 C12N15/88
To view Oncorus’s complete patent history, request access »

Oncorus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncorus ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Oncorus’s complete esg history, request access »

Oncorus Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Oncorus Securities Corporation Foxboro, MA

Oncorus FAQs

  • When was Oncorus founded?

    Oncorus was founded in 2015.

  • Where is Oncorus headquartered?

    Oncorus is headquartered in Andover, MA.

  • What is the size of Oncorus?

    Oncorus has 64 total employees.

  • What industry is Oncorus in?

    Oncorus’s primary industry is Drug Discovery.

  • Is Oncorus a private or public company?

    Oncorus is a Private company.

  • What is Oncorus’s current revenue?

    The current revenue for Oncorus is .

  • How much funding has Oncorus raised over time?

    Oncorus has raised $295M.

  • Who are Oncorus’s competitors?

    Iovance Biotherapeutics, Genelux, Adaptimmune Therapeutics, Xenetic Biosciences, and Corbus Pharmaceuticals Holdings are some of the 97 competitors of Oncorus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process